{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:47:32Z","timestamp":1781372852608,"version":"3.54.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05796-2","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:23:07Z","timestamp":1732792987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The role of cerebrospinal fluid metabolites in mediating the impact of lipids on Late-Onset Alzheimer\u2019s Disease: a two-step mendelian randomization analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jie","family":"Jie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9812-473X","authenticated-orcid":false,"given":"Su","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"5796_CR1","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Disease facts and figures. Alzheimers Dement. 2022;18:700\u201389.","DOI":"10.1002\/alz.12638"},{"key":"5796_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"Emma Nichols","year":"2019","unstructured":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18:88\u2013106.","journal-title":"Lancet Neurol"},{"key":"5796_CR3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1186\/s12967-023-04646-x","volume":"21","author":"X-H Hou","year":"2023","unstructured":"Hou X-H, Suckling J, Shen X-N, Liu Y, Zuo C-T, Huang Y-Y, et al. Multipredictor risk models for predicting individual risk of Alzheimer\u2019s disease. J Translational Med. 2023;21:768.","journal-title":"J Translational Med"},{"key":"5796_CR4","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nat Rev Dis Primers. 2015;1:15056.","journal-title":"Nat Rev Dis Primers"},{"key":"5796_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s41467-023-37304-3","volume":"14","author":"V Lau","year":"2023","unstructured":"Lau V, Ramer L, Tremblay M-\u00c8. An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer\u2019s disease. Nat Commun. 2023;14:1670.","journal-title":"Nat Commun"},{"key":"5796_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","volume":"36","author":"RW Mahley","year":"2016","unstructured":"Mahley RW. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. Arterioscler Thromb Vasc Biol. 2016;36:1305\u201315.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5796_CR7","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45:1452\u20138.","journal-title":"Nat Genet"},{"key":"5796_CR8","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.3390\/nu15133013","volume":"15","author":"J He","year":"2023","unstructured":"He J, Huang M, Li N, Zha L, Yuan J. Genetic Association and Potential Mediators between Sarcopenia and Coronary Heart Disease: A Bidirectional Two-Sample, Two-Step Mendelian Randomization Study. Nutrients. 2023;15:3013.","journal-title":"Nutrients"},{"key":"5796_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11883-012-0307-3","volume":"15","author":"C Reitz","year":"2013","unstructured":"Reitz C. Dyslipidemia and the Risk of Alzheimer\u2019s Disease. Curr Atheroscler Rep. 2013;15:307.","journal-title":"Curr Atheroscler Rep"},{"key":"5796_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2012.12.042","volume":"536","author":"JD Mills","year":"2013","unstructured":"Mills JD, Nalpathamkalam T, Jacobs HIL, Janitz C, Merico D, Hu P, et al. RNA-Seq analysis of the parietal cortex in Alzheimer\u2019s disease reveals alternatively spliced isoforms related to lipid metabolism. Neurosci Lett. 2013;536:90\u20135.","journal-title":"Neurosci Lett"},{"key":"5796_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archneur.61.5.661","volume":"61","author":"Z Arvanitakis","year":"2004","unstructured":"Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661\u20136.","journal-title":"Arch Neurol"},{"key":"5796_CR12","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/j.1471-4159.2008.05454.x","volume":"106","author":"GM Pasinetti","year":"2008","unstructured":"Pasinetti GM, Eberstein JA, METABOLIC SYNDROME AND THE ROLE OF DIETARY, LIFESTYLES IN ALZHEIMER\u2019S DISEASE. J Neurochem. 2008;106:1503\u201314.","journal-title":"J Neurochem"},{"key":"5796_CR13","doi-asserted-by":"publisher","first-page":"e31501","DOI":"10.1371\/journal.pone.0031501","volume":"7","author":"C Czech","year":"2012","unstructured":"Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V, et al. Metabolite Profiling of Alzheimer\u2019s Disease Cerebrospinal Fluid. PLoS ONE. 2012;7:e31501.","journal-title":"PLoS ONE"},{"key":"5796_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40364-018-0119-x","volume":"6","author":"Y Nagata","year":"2018","unstructured":"Nagata Y, Hirayama A, Ikeda S, Shirahata A, Shoji F, Maruyama M, et al. Comparative analysis of cerebrospinal fluid metabolites in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort. Biomark Res. 2018;6:5.","journal-title":"Biomark Res"},{"key":"5796_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s42003-020-01583-z","volume":"4","author":"DJ Panyard","year":"2021","unstructured":"Panyard DJ, Kim KM, Darst BF, Deming YK, Zhong X, Wu Y, et al. Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations. Commun Biol. 2021;4:63.","journal-title":"Commun Biol"},{"key":"5796_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","volume":"7","author":"LM Refolo","year":"2000","unstructured":"Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, et al. Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model. Neurobiol Dis. 2000;7:321\u201331.","journal-title":"Neurobiol Dis"},{"key":"5796_CR17","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000;57:1439\u201343.","journal-title":"Arch Neurol"},{"key":"5796_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Tanzi RE, Kovacs DM. Alzheimer\u2019s disease: the cholesterol connection. Nat Neurosci. 2003;6:345\u201351.","journal-title":"Nat Neurosci"},{"key":"5796_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12967-022-03786-w","volume":"20","author":"Q Wang","year":"2022","unstructured":"Wang Q, Zang F, He C, Zhang Z, Xie C. Alzheimer\u2019s Disease Neuroimaging Initiative. Dyslipidemia induced large-scale network connectivity abnormality facilitates cognitive decline in the Alzheimer\u2019s disease. J Translational Med. 2022;20:567.","journal-title":"J Translational Med"},{"key":"5796_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"G Davey Smith","year":"2003","unstructured":"Davey Smith G, Ebrahim S. Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1\u201322.","journal-title":"Int J Epidemiol"},{"key":"5796_CR21","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","journal-title":"BMJ"},{"key":"5796_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ije\/dyh132","volume":"33","author":"GD Smith","year":"2004","unstructured":"Smith GD, Ebrahim S. Mendelian randomization: Prospects, potentials, and limitations. Int J Epidemiol. 2004;33:30\u201342.","journal-title":"Int J Epidemiol"},{"key":"5796_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364.","journal-title":"Int J Epidemiol"},{"key":"5796_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00438-024-02125-6","volume":"299","author":"Y-F Qiu","year":"2024","unstructured":"Qiu Y-F, Ye J, Xie J-J, Mao X-T, Liu Y-L, Fang Q, et al. Pancreatitis affects gut microbiota via metabolites and inflammatory cytokines: an exploratory two-step Mendelian randomisation study. Mol Genet Genomics. 2024;299:36.","journal-title":"Mol Genet Genomics"},{"key":"5796_CR25","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021;326:1614\u201321.","journal-title":"JAMA"},{"key":"5796_CR26","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","volume":"14","author":"L Ottensmann","year":"2023","unstructured":"Ottensmann L, Tabassum R, Ruotsalainen SE, Gerl MJ, Klose C, Wid\u00e9n E, et al. Genome-wide association analysis of plasma lipidome identifies 495 genetic associations. Nat Commun. 2023;14:6934.","journal-title":"Nat Commun"},{"key":"5796_CR27","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53:1276\u201382.","journal-title":"Nat Genet"},{"key":"5796_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023;55:44\u201353.","journal-title":"Nat Genet"},{"key":"5796_CR29","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrology: JASN. 2016;27:3253\u201365.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"5796_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-023-02761-6","volume":"21","author":"Y Long","year":"2023","unstructured":"Long Y, Tang L, Zhou Y, Zhao S, Zhu H. Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study. BMC Med. 2023;21:66.","journal-title":"BMC Med"},{"key":"5796_CR31","doi-asserted-by":"publisher","first-page":"e1009922","DOI":"10.1371\/journal.pgen.1009922","volume":"17","author":"Z Lin","year":"2021","unstructured":"Lin Z, Deng Y, Pan W. Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model. PLoS Genet. 2021;17:e1009922.","journal-title":"PLoS Genet"},{"key":"5796_CR32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data. Genet Epidemiol. 2013;37:658\u201365.","journal-title":"Genet Epidemiol"},{"key":"5796_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40:304\u201314.","journal-title":"Genet Epidemiol"},{"key":"5796_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"5796_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ije\/dyu176","volume":"44","author":"S Burgess","year":"2015","unstructured":"Burgess S, Daniel RM, Butterworth AS, Thompson SG, the EPIC-InterAct Consortium. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol. 2015;44:484\u201395.","journal-title":"Int J Epidemiol"},{"key":"5796_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/ije\/dyr233","volume":"41","author":"CL Relton","year":"2012","unstructured":"Relton CL, Davey Smith G. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41:161\u201376.","journal-title":"Int J Epidemiol"},{"key":"5796_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389.","journal-title":"Eur J Epidemiol"},{"key":"5796_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"5796_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jclinepi.2014.09.005","volume":"68","author":"JF Cohen","year":"2015","unstructured":"Cohen JF, Chalumeau M, Cohen R, Korevaar DA, Khoshnood B, Bossuyt PMM. Cochran\u2019s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy. J Clin Epidemiol. 2015;68:299\u2013306.","journal-title":"J Clin Epidemiol"},{"key":"5796_CR40","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173\u201382.","journal-title":"J Pers Soc Psychol"},{"key":"5796_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/01.JGP.0000310778.20870.ae","volume":"16","author":"KJ Anstey","year":"2008","unstructured":"Anstey KJ, Lipnicki DM, Low L-F. Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis. Am J Geriatric Psychiatry: Official J Am Association Geriatric Psychiatry. 2008;16:343\u201354.","journal-title":"Am J Geriatric Psychiatry: Official J Am Association Geriatric Psychiatry"},{"key":"5796_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000026149","volume":"17","author":"IL Notkola","year":"1998","unstructured":"Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u2019s disease. Neuroepidemiology. 1998;17:14\u201320.","journal-title":"Neuroepidemiology"},{"key":"5796_CR43","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","volume":"64","author":"MM Mielke","year":"2005","unstructured":"Mielke MM, Zandi PP, Sj\u00f6gren M, Gustafson D, \u00d6stling S, Steen B, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64:1689\u201395.","journal-title":"Neurology"},{"key":"5796_CR44","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.3390\/ijms22094547","volume":"22","author":"EW Kjeldsen","year":"2021","unstructured":"Kjeldsen EW, Nordestgaard LT, Frikke-Schmidt R. HDL cholesterol and non-cardiovascular disease: A narrative review. Int J Mol Sci. 2021;22:4547.","journal-title":"Int J Mol Sci"},{"key":"5796_CR45","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1212\/WNL.0b013e31822e145d","volume":"77","author":"T Matsuzaki","year":"2011","unstructured":"Matsuzaki T, Sasaki K, Hata J, Hirakawa Y, Fujimi K, Ninomiya T, et al. Association of alzheimer disease pathology with abnormal lipid metabolism. Neurology. 2011;77:1068\u201375.","journal-title":"Neurology"},{"key":"5796_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/JAD-160826","volume":"56","author":"KJ Anstey","year":"2017","unstructured":"Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: Review and meta-analysis. J Alzheimers Dis. 2017;56:215.","journal-title":"J Alzheimers Dis"},{"key":"5796_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","volume":"35","author":"L Whiley","year":"2014","unstructured":"Whiley L, Sen A, Heaton J, Proitsi P, Garc\u00eda-G\u00f3mez D, Leung R, et al. Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease. Neurobiol Aging. 2014;35:271\u20138.","journal-title":"Neurobiol Aging"},{"key":"5796_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.plipres.2011.06.001","volume":"50","author":"V Frisardi","year":"2011","unstructured":"Frisardi V, Panza F, Seripa D, Farooqui T, Farooqui AA. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer\u2019s disease pathology. Prog Lipid Res. 2011;50:313\u201330.","journal-title":"Prog Lipid Res"},{"key":"5796_CR49","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.pnpbp.2010.08.019","volume":"34","author":"EL Schaeffer","year":"2010","unstructured":"Schaeffer EL, da Silva ER, Novaes B, de Skaf A, Gattaz HD. Differential roles of phospholipases A2 in neuronal death and neurogenesis: implications for Alzheimer disease. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1381\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5796_CR50","doi-asserted-by":"publisher","first-page":"506160","DOI":"10.5402\/2012\/506160","volume":"2012","author":"T Kolter","year":"2012","unstructured":"Kolter T. Ganglioside Biochemistry. ISRN Biochem. 2012;2012:506160.","journal-title":"ISRN Biochem"},{"key":"5796_CR51","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.ejcn.1601704","volume":"57","author":"B Wang","year":"2003","unstructured":"Wang B, Brand-Miller J. The role and potential of sialic acid in human nutrition. Eur J Clin Nutr. 2003;57:1351\u201369.","journal-title":"Eur J Clin Nutr"},{"key":"5796_CR52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00033.2013","volume":"94","author":"RL Schnaar","year":"2014","unstructured":"Schnaar RL, Gerardy-Schahn R, Hildebrandt H. Sialic Acids in the Brain: Gangliosides and Polysialic Acid in Nervous System Development, Stability, Disease, and Regeneration. Physiol Rev. 2014;94:461\u2013518.","journal-title":"Physiol Rev"},{"key":"5796_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.abb.2004.02.019","volume":"426","author":"RL Schnaar","year":"2004","unstructured":"Schnaar RL. Glycolipid-mediated cell-cell recognition in inflammation and nerve regeneration. Arch Biochem Biophys. 2004;426:163\u201372.","journal-title":"Arch Biochem Biophys"},{"key":"5796_CR54","doi-asserted-by":"publisher","first-page":"S465","DOI":"10.3945\/an.112.001875","volume":"3","author":"B Wang","year":"2012","unstructured":"Wang B. Molecular mechanism underlying sialic acid as an essential nutrient for brain development and cognition. Adv Nutr. 2012;3:S465\u201372.","journal-title":"Adv Nutr"},{"key":"5796_CR55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.nutr.28.061807.155515","volume":"29","author":"B Wang","year":"2009","unstructured":"Wang B. Sialic Acid Is an Essential Nutrient for Brain Development and Cognition. Annu Rev Nutr. 2009;29:177\u2013222.","journal-title":"Annu Rev Nutr"},{"key":"5796_CR56","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/10409238.2014.976606","volume":"49","author":"KJ Colley","year":"2014","unstructured":"Colley KJ, Kitajima K, Sato C. Polysialic acid: biosynthesis, novel functions and applications. Crit Rev Biochem Mol Biol. 2014;49:498\u2013532.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"5796_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","volume":"37","author":"WA Banks","year":"2010","unstructured":"Banks WA, Erickson MA. The blood\u2013brain barrier and immune function and dysfunction. Neurobiol Dis. 2010;37:26\u201332.","journal-title":"Neurobiol Dis"},{"key":"5796_CR58","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cell.2018.02.017","volume":"173","author":"SL Zhang","year":"2018","unstructured":"Zhang SL, Yue Z, Arnold DM, Artiushin G, Sehgal A. A Circadian Clock in the Blood-Brain Barrier Regulates Xenobiotic Efflux. Cell. 2018;173:130\u2013e13910.","journal-title":"Cell"},{"key":"5796_CR59","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","volume":"37","author":"S Sivanand","year":"2020","unstructured":"Sivanand S, Vander Heiden MG. Emerging roles for branched chain amino acid metabolism in cancer. Cancer Cell. 2020;37:147\u201356.","journal-title":"Cancer Cell"},{"key":"5796_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.phrs.2018.05.014","volume":"133","author":"Y Shimomura","year":"2018","unstructured":"Shimomura Y, Kitaura Y. Physiological and pathological roles of branched-chain amino acids in the regulation of protein and energy metabolism and neurological functions. Pharmacol Res. 2018;133:215\u20137.","journal-title":"Pharmacol Res"},{"key":"5796_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.chroma.2013.06.005","volume":"1302","author":"C Ib\u00e1\u00f1ez","year":"2013","unstructured":"Ib\u00e1\u00f1ez C, Sim\u00f3 C, Barupal DK, Fiehn O, Kivipelto M, Cedazo-M\u00ednguez A, et al. A new metabolomic workflow for early detection of Alzheimer\u2019s disease. J Chromatogr A. 2013;1302:65\u201371.","journal-title":"J Chromatogr A"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05796-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05796-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05796-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T13:05:18Z","timestamp":1732799118000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05796-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5796"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05796-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have disclosed no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1077"}}